Gufic BioSciences Share Price

NSE
GUFICBIO •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Gufic BioSciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
46.08% Gain from 52W Low
15.4
TTM PE Ratio
Below industry Median
47.9
Price to Book Ratio
Above industry Median
7.6
Dividend yield 1yr %
0.02
TTM PEG Ratio
PEG TTM is less than 1
0.5

Gufic BioSciences Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Gufic BioSciences Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
204.18 Cr
202.81 Cr
194.99 Cr
201.78 Cr
214.87 Cr

Gufic BioSciences Ltd Yearly Revenue

Mar 2024
808.84 Cr

Gufic BioSciences Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
21.77 Cr
20.86 Cr
20.05 Cr
22.26 Cr
23.21 Cr

Gufic BioSciences Ltd Yearly Net Profit/Loss

Mar 2024
86.14 Cr

Gufic BioSciences Ltd shareholding Pattern

Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.5%
Domestic Institutions
2.5%
Public
24.8%
Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.3%
Domestic Institutions
2.4%
Public
24.9%
Promoter
72.5%
Foreign Institutions
0.1%
Mutual Funds
2.1%
Domestic Institutions
2.2%
Public
25.2%
Promoter
72.5%
Foreign Institutions
0.5%
Mutual Funds
1.6%
Domestic Institutions
1.7%
Public
25.3%
Promoter
75%
Foreign Institutions
0.7%
Mutual Funds
1.5%
Domestic Institutions
1.6%
Public
22.6%
Promoter
75%
Foreign Institutions
0.7%
Mutual Funds
1%
Domestic Institutions
1.2%
Public
23.1%

Gufic BioSciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
423.20
10Day EMA
433.90
12Day EMA
435.60
20Day EMA
435.90
26Day EMA
433.50
50Day EMA
420.60
100Day EMA
397.80
200Day EMA
366.70
5Day SMA
424.10
10Day SMA
445.50
20Day SMA
442.50
30Day SMA
434.80
50Day SMA
418.60
100Day SMA
391.80
150Day SMA
371.70
200Day SMA
356.50
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
31328 Rs
67722 Rs
Week Rs
53973 Rs
114923 Rs
Month Rs
62639 Rs
177424 Rs
Resistance & Support
407.83
Pivot
Resistance
First Resistance
419.47
Second Resistance
433.33
Third Resistance
444.97
Support
First Support
393.97
Second support
382.33
Third Support
368.47
Relative Strength Index
41.32
Money Flow Index
76.73
MACD
2.06
MACD Signal
9.50
Average True Range
25.35
Average Directional Index
31.49
Rate of Change (21)
-9.90
Rate of Change (125)
17.50

Gufic BioSciences Ltd Company background

Founded in: 1984
Managing director: Jayesh P Choksi
Gufic Biosciences (GBL) was incorporated in Jul84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 4042 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a longstanding presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market. The company plan to invest further in RD activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 202021, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.
Read More

Gufic BioSciences Ltd FAQs

Gufic BioSciences Ltd shares are currently priced at 405.6 on NSE and 407.85 on BSE as of 11/19/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Gufic BioSciences Ltd [GUFICBIO] share was 31.62. The Gufic BioSciences Ltd [GUFICBIO] share hit a 1-year low of Rs. 277.65 and a 1-year high of Rs. 504.25.

The market cap of Gufic BioSciences Ltd is Rs. 4067.26 Cr. as of 11/19/2024 12:00:00 AM.

The PE ratios of Gufic BioSciences Ltd is 48.15 as of 11/19/2024 12:00:00 AM.

The PB ratios of Gufic BioSciences Ltd is 7.12 as of 11/19/2024 12:00:00 AM

The Mutual Fund Shareholding was 2.51% at the end of 11/19/2024 12:00:00 AM.

You can easily buy Gufic BioSciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -